IN2012CH01309A - - Google Patents

Download PDF

Info

Publication number
IN2012CH01309A
IN2012CH01309A IN1309CH2012A IN2012CH01309A IN 2012CH01309 A IN2012CH01309 A IN 2012CH01309A IN 1309CH2012 A IN1309CH2012 A IN 1309CH2012A IN 2012CH01309 A IN2012CH01309 A IN 2012CH01309A
Authority
IN
India
Prior art keywords
present
ivabradine
hydro
preparation
provides
Prior art date
Application number
Other languages
English (en)
Inventor
Reddy Bandi Parthasaradhi
Reddy Kura Rathnakar
Reddy Dasari Muralidhara
Rao Thungathurthy Srinivasa
Krishna Bandi Vamsi
Original Assignee
Hetero Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Research Foundation filed Critical Hetero Research Foundation
Priority to IN1309CH2012 priority Critical patent/IN2012CH01309A/en
Priority to PCT/IN2013/000212 priority patent/WO2013150544A2/en
Publication of IN2012CH01309A publication Critical patent/IN2012CH01309A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
IN1309CH2012 2012-04-02 2013-04-01 IN2012CH01309A (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN1309CH2012 IN2012CH01309A (pl) 2012-04-02 2013-04-01
PCT/IN2013/000212 WO2013150544A2 (en) 2012-04-02 2013-04-01 Ivabradine hydrochloride solid dispersion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1309CH2012 IN2012CH01309A (pl) 2012-04-02 2013-04-01

Publications (1)

Publication Number Publication Date
IN2012CH01309A true IN2012CH01309A (pl) 2015-06-19

Family

ID=49301127

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1309CH2012 IN2012CH01309A (pl) 2012-04-02 2013-04-01

Country Status (2)

Country Link
IN (1) IN2012CH01309A (pl)
WO (1) WO2013150544A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3122362A1 (en) * 2014-03-27 2017-02-01 Laboratorio Chimico Internazionale S.p.A. Ivabradine adsorbates
WO2016009314A1 (en) * 2014-07-18 2016-01-21 Sifavitor S.R.L. "amorphous mixture of ivabradine and chrysin"
CN104230808B (zh) * 2014-08-22 2016-05-18 苏州亚宝药物研发有限公司 无定形盐酸伊伐布雷定及其制备方法与应用
WO2016102423A1 (en) 2014-12-22 2016-06-30 Ratiopharm Gmbh Composition comprising ivabradine in a dissolved form

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101677955A (zh) * 2007-03-12 2010-03-24 雷迪博士实验室有限公司 甲磺酸伊马替尼
EP2471780B1 (en) * 2007-05-30 2014-11-26 Ind-Swift Laboratories Limited Crystalline Ivabradine Oxalate Salts and Polymorphs Thereof
EA201290772A1 (ru) * 2010-02-12 2013-02-28 КРКА, д.д., НОВО МЕСТО Новые формы ивабрадина гидрохлорида
HUP1000245A2 (en) * 2010-05-07 2011-11-28 Richter Gedeon Nyrt Industrial process for the production ivabradin salts

Also Published As

Publication number Publication date
WO2013150544A2 (en) 2013-10-10
WO2013150544A3 (en) 2013-12-05

Similar Documents

Publication Publication Date Title
IL279304A (en) History of cytotoxic benzodiazepines, preparations containing them and their uses
ZA201405101B (en) "new indolizine compounds, a process for their preparation and pharmaceutical compositions containing them."
IL230218A (en) Converted atherothecyclic compounds, their preparations and their pharmaceutical preparations
IL233154A (en) Compounds, pharmaceuticals containing them and their uses
SI2379511T1 (sl) Substituirani diketopiperazinski analogi za uporabo kot sredstva za dostavo zdravil
IL221952A (en) Annotations 2, 3-Dihydro-1h - Indene-1-Il-7,2- Diazaspiro [5.3] Noonan and Pharmaceuticals Containing Them
MX359288B (es) Forma iv del clorhidrato de ivabradina.
WO2014076712A3 (en) Lurasidone hydrochloride solid dispersion
TW200942524A (en) Novel aminomethyl benzene derivatives
PL2531505T3 (pl) Sposób wytwarzania kompleksów 3,7-diaza-bicyklo[3.3.1]nonanu z metalami
MX348393B (es) Polimorfo de rifaximina y proceso para la preparacion del mismo.
IL217053A0 (en) Nanoparticulate candesarten cilexetil compositions, process for the preparation thereof and pharmaceutical compositions containing them
ZA201401710B (en) "new administration regime for n-hydroxy-4-{-3-(n,n-dimethylamethyl)benzofurun-2 ylcarbonylamino]ethoxy}benzaminde"
WO2014062838A3 (en) Pkm2 modulators and methods for their use
PT2504331E (pt) Composto, novas formas desse composto, composições farmacêuticas desse composto e métodos de preparação e utilização
IN2012CH01309A (pl)
EP2692777A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING A BLOCK COPOLYMER AND A BORIC ACID COMPOUND
UA103996C2 (en) Ivabradine hydrobromide
EP2784061A4 (en) ACYLHYDRACO AND OXADIAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE THEREOF
WO2014009970A3 (en) Linagliptin solid dispersion
EP2871187A4 (en) NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT
WO2014115169A3 (en) Crizotinib solid dispersion
WO2014013511A3 (en) Rufinamide solid dispersion
IL218764A (en) Crystalline lupilopinic acid and the process for its preparation, its uses, and its pharmaceutical preparations
HK1176355A1 (en) Dihydro oxazolobenzodiazepinone compounds, a process for their preparation and pharmaceutical compositions containing them